Xtandi 40mg

Xtandi 40mg capsules contain the active ingredient Enzalutamide. This antineoplastic medication falls under the category of androgen receptor inhibitors. It is prescribed for the treatment of advanced prostate cancer in patients who have not responded to surgical or hormonal therapies.

If you are allergic to any of the ingredients, it is advised not to take these capsules. Throughout the treatment, your physician may conduct periodic Prostate-specific antigen (PSA) tests. This blood test assesses the PSA level, a protein produced by the prostate gland that may be elevated in men with prostate cancer. Monitoring PSA levels can provide insights into the disease’s progression and the effectiveness of the treatment. Additional tests may include liver function assessments and a complete blood count (CBC) to mitigate serious complications.

This medication has the potential to induce seizures; therefore, patients with a seizure history should exercise caution when using it. It is important to avoid grapefruit and grapefruit juice while on this medication, as they can elevate the drug’s levels in the body. This drug is contraindicated during pregnancy due to potential harm to the unborn child and may also lead to fertility issues. Inform your doctor of any fertility concerns prior to commencing treatment with this medication. Before starting this treatment, notify your healthcare provider if you are pregnant or planning to conceive. It is recommended for both men and women to adhere to effective contraceptive methods during treatment and for three months following the final dose of Xtandi 40mg capsules.